Alerts will be sent to your verified email
Verify EmailSUVENPHAR
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Suven Pharmaceuticals Limited is a bio-pharmaceutical company specializing in the development and manufacturing of New Chemical Entity (NCE) based Intermediates, API, Speciality Chemicals, and formulated drugs for global pharmaceutical, biotechnology, and chemical companies.
Suven Pharma major competitors are Jubilant Pharmova, Syngene Internation., Piramal Pharma, Hikal, Suven Life Sciences, Sun Pharma Adv. Res, Dishman Carbogen Amc.
Market Cap of Suven Pharma is ₹30,656 Crs.
While the median market cap of its peers are ₹5,142 Crs.
Suven Pharma seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
Earnings Release | Jun Sep Dec | Mar Jun | Mar Jun Sep Dec | Dec | ||||||||||||||
Investor Presentation | Jan Feb Mar Jun Sep Dec | Jan Mar Jun Sep Nov Dec | Mar May Jun Aug Sep Dec | Mar Jun Sep Dec | Mar Jun Sep | Dec | ||||||||||||
Conference Call | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar | Mar Jun Sep Dec | |||||||||||||
Conference Call SummaryCon Call Summary
Powered by Gemini
|